Diagnostic aids for TBI based on GFAP and another blood-based biomarker– ubiquitin C-terminal hydrolase-L1 (UCH-L1) – have recently obtained regulatory approval (Banyan Brain Trauma Indicator Test. This evidence concerns the gene UCHL1 and brain injury.